Načítá se...
CRISPR Correction of Duchenne Muscular Dystrophy
The ability to efficiently modify the genome using CRISPR technology has rapidly revolutionized biology and genetics and will soon transform medicine. Duchenne muscular dystrophy (DMD) represents one of the first monogenic disorders that has been investigated with respect to CRISPR-mediated correcti...
Uloženo v:
| Vydáno v: | Annu Rev Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6415693/ https://ncbi.nlm.nih.gov/pubmed/30379597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1146/annurev-med-081117-010451 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|